Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.15%72.471.2%$698.33m
CELGCelgene Corporation
0.71%117.391.3%$685.14m
AMGNAmgen Inc.
-0.15%145.071.0%$640.82m
BIIBBiogen Inc.
0.25%290.961.2%$543.42m
REGNRegeneron Pharmaceuticals, Inc.
-0.24%368.953.6%$400.43m
ALXNAlexion Pharmaceuticals, Inc.
-0.61%124.171.9%$372.24m
ILMNIllumina, Inc.
-1.19%126.403.0%$184.89m
VRTXVertex Pharmaceuticals Incorporated
3.40%78.122.9%$171.61m
INCYIncyte Corporation
2.34%107.212.4%$169.49m
TSROTESARO, Inc.
0.22%139.8717.1%$164.06m
IONSIonis Pharmaceuticals, Inc.
3.15%47.4510.0%$156.72m
EXELExelixis, Inc.
2.36%18.256.4%$128.45m
BLUEBluebird Bio, Inc.
9.43%78.9523.3%$121.32m
BMRNBioMarin Pharmaceutical Inc.
0.66%82.994.5%$116.36m
AAgilent Technologies, Inc.
0.72%44.851.6%$114.69m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.